Flexogenix

For millions of patients experiencing joint pain, facing the prospect of joint replacement surgery along with all of the associated risks and potential unwanted side effects, Flexogenix provides a cost-effective nonsurgical alternative with little to no post-procedural downtime, with most patients able to resume normal activity the same day of the procedure. Treatments are physician administered, FDA approved and, in most cases, completely covered by medical insurance. We custom tailor treatment to each persons individual needs. Flexogenix offers a no-obligation consultation. If you are a candidate, a medical evaluation will follow and you will receive a detailed treatment plan capitalizing...

Viscosupplementation,pain management,medical imaging,regenerative medicine,physical medicine & rehabilitation,and sports medicine

Flexogenix operates in the Medical practices industry.

Flexogenix's revenue is 11m - 100m

Flexogenix has 11 - 50 employees.